CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

GRACE

A. Goodman, A. Jeong, S. Rajeeve

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

Drug Allergy

Mariana Castells

CAR T-Cell Therapy in Autoimmune Disorders

Vanderbilt University Medical Center (VUMC)

O. Oluwole

CAR T-Cell Therapy Side Effects for Blood Cancers

GRACE

A. Goodman

CAR NK Cells: Next Generation Cell Therapies for Cancer

University of Colorado Cancer Center

K. Rezvani

The Improbable History of CAR T-Cells

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

C. June

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

Malkhaz Mizandari

SIR 2024 Insights: Route90 US IDE Pivotal Study Early Results in Rad…

SIR 2024 Insights

A. Kennedy

Interventional Delivery of CAR-T Therapy

Michael Soulen

Bispecific vs. Combination Therapy - PRO Combination Therapy

ImmunoTherapy Bridge 2023

A. Patnaik

CAR T-Cell Failure: Mechanisms and Salvage Options

Beth Israel Deaconess Medical Center

J. Arnason

Bispecific vs. Combination Therapy - PRO Bispecific

ImmunoTherapy Bridge 2023

J. Gulley

Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…

Penn Medicine Abramson Cancer Center

M. Soulen

Treatment of Symptomatic Brain Metastases in Melanoma: Combination o…

Melanoma Bridge 2023

H. Tawbi

Innovating Immunotherapy for Pancreatic Cancer

ImmunoTherapy Bridge 2023

G. Lesinski

Bispecific Antibodies and CAR T-Cells for NHL: Challenges and Opport…

Total Health

K. Komanduri

CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities

UNC Lineberger Comprehensive Cancer Center

M. Mcelfresh